tirzepatide off shortage Lilly's weight-loss drug removed from FDA's list ๐จ Alert: Tirzepatide No Longer
Description
This dual action results in superior glycemic control and weight reduction compared to selective GLP-1 receptor agonists in clinical trials
Focus on leafy greens, broccoli, cauliflower, bell peppers, zucchini, asparagus, and green beans
Because perimenopause and menopause cause hormonal changes like weight gain and metabolic changes, Tirzepatide may be a helpful option
No multiplicity adjustments were made in assessing secondary parameters
Starting in January 2025, Ozempic gained FDA approval for reducing kidney disease risks in adults with type 2 diabetes who also have chronic kidney disease
Schedule a visit with an Ivim provider to discuss what this means for you and your treatment options
